Published in Mayo Clin Proc on April 01, 2003
Treating type 2 diabetes mellitus: a growing epidemic. Mayo Clin Proc (2003) 0.81
Apoptosis rate and transcriptional response of pancreatic islets exposed to the PPAR gamma agonist Pioglitazone. Diabetol Metab Syndr (2013) 0.78
Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options. Ther Clin Risk Manag (2015) 0.78
Patient factors associated with hemoglobin A1C change with pioglitazone as adjunctive therapy in type 2 Diabetes Mellitus. Pharm Pract (Granada) (2008) 0.75
DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med (2006) 7.90
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care (2004) 2.93
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol (2009) 2.92
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes (2003) 2.53
Posttransplantation diabetes: a systematic review of the literature. Diabetes Care (2002) 2.39
Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes (2006) 2.20
Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab (2003) 1.92
Moyamoya disease in a primarily white, midwestern US population: increased prevalence of autoimmune disease. Stroke (2013) 1.68
Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes (2013) 1.51
Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes (2012) 1.46
Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab (2008) 1.39
Closed-loop artificial pancreas systems: physiological input to enhance next-generation devices. Diabetes Care (2014) 1.37
Time lag of glucose from intravascular to interstitial compartment in humans. Diabetes (2013) 1.32
Endocrinopathy in POEMS syndrome: the Mayo Clinic experience. Mayo Clin Proc (2007) 1.29
Hyperoxia blunts counterregulation during hypoglycaemia in humans: possible role for the carotid bodies? J Physiol (2010) 1.28
Skin blood flow and nitric oxide during body heating in type 2 diabetes mellitus. J Appl Physiol (1985) (2008) 1.27
Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol (2005) 1.25
Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant (2005) 1.20
Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men. Diabetes Care (2007) 1.20
Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes. Cancer Res (2008) 1.19
Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Mol Ther (2012) 1.19
Liver is the site of splanchnic cortisol production in obese nondiabetic humans. Diabetes (2008) 1.17
Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care (2008) 1.17
Contribution of nitric oxide to cutaneous microvascular dilation in individuals with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab (2006) 1.16
Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway. Diabetes (2004) 1.16
Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. Stem Cell Res Ther (2011) 1.12
Postprandial glucose fluxes and insulin sensitivity during exercise: a study in healthy individuals. Am J Physiol Endocrinol Metab (2013) 1.09
Delayed threshold for active cutaneous vasodilation in patients with Type 2 diabetes mellitus. J Appl Physiol (1985) (2005) 1.07
Quantitative estimation of insulin sensitivity in type 1 diabetic subjects wearing a sensor-augmented insulin pump. Diabetes Care (2013) 1.07
Long-term benefits of pancreas transplantation. Curr Opin Organ Transplant (2008) 1.05
Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans. J Clin Endocrinol Metab (2005) 1.05
Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia. J Clin Endocrinol Metab (2013) 1.04
Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women. Diabetes (2007) 1.04
Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. PLoS One (2013) 1.00
Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes. Diabetes (2007) 1.00
Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation. Transplantation (2010) 0.99
Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials. Clin Endocrinol (Oxf) (2008) 0.99
The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people. Diabetes Care (2012) 0.98
Melanin concentrating hormone is a novel regulator of islet function and growth. Diabetes (2007) 0.98
GPR40 modulators: new kid on the block. Diabetes Care (2013) 0.96
Metabolic and target organ outcomes after total pancreatectomy: Mayo Clinic experience and meta-analysis of the literature. Clin Endocrinol (Oxf) (2010) 0.94
Transaldolase exchange and its effects on measurements of gluconeogenesis in humans. Am J Physiol Endocrinol Metab (2010) 0.94
Effect of nutrient ingestion on total-body and splanchnic cortisol production in humans. Diabetes (2006) 0.93
Additional evidence that transaldolase exchange, isotope discrimination during the triose-isomerase reaction, or both occur in humans: effects of type 2 diabetes. Diabetes (2009) 0.92
Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes (2002) 0.92
Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin. Endocr Pract (2007) 0.91
Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus. Pancreas (2011) 0.91
Exercise, hypoglycemia, and type 1 diabetes. Diabetes Technol Ther (2014) 0.91
Diabetes Mellitus Is Associated With an Exocrine Pancreatopathy: Conclusions From a Review of Literature. Pancreas (2016) 0.91
Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy. Dis Model Mech (2013) 0.91
Physical activity measured by physical activity monitoring system correlates with glucose trends reconstructed from continuous glucose monitoring. Diabetes Technol Ther (2013) 0.90
Modeling hepatic insulin sensitivity during a meal: validation against the euglycemic hyperinsulinemic clamp. Am J Physiol Endocrinol Metab (2013) 0.90
Gastric bypass surgery is associated with near-normal insulin suppression of lipolysis in nondiabetic individuals. Am J Physiol Endocrinol Metab (2011) 0.90
Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes. Diabetes (2012) 0.88
Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc (2005) 0.88
Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunction. Transplantation (2011) 0.87
Hypoglycemia requiring ambulance services in patients with type 2 diabetes is associated with increased long-term mortality. Endocr Pract (2013) 0.87
Current state of diabetes technology clinics and programs in the United States. J Diabetes Sci Technol (2013) 0.86
Circadian variability of insulin sensitivity: physiological input for in silico artificial pancreas. Diabetes Technol Ther (2015) 0.86
Population-based study of hypoglycemia in patients with type 1 diabetes mellitus requiring emergency medical services. Endocr Pract (2012) 0.85
Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells. Stem Cell Res Ther (2011) 0.85
Effect of hyperglycemia on human monocyte activation. J Investig Med (2011) 0.83
Immediate post-resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors. HPB (Oxford) (2012) 0.83
Role of AKT-glycogen synthase kinase axis in monocyte activation in human beings with and without type 2 diabetes. J Cell Mol Med (2009) 0.83
Both vascular endothelial growth factor and soluble Flt-1 are increased in type 2 diabetes but not in impaired fasting glucose. J Investig Med (2010) 0.82
Glucose control in Mayo Clinic intensive care units. J Diabetes Sci Technol (2011) 0.82
Hepatic 11β-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique. Diabetologia (2014) 0.81
Systematic review and meta-analysis: islet autotransplantation after pancreatectomy for minimizing diabetes. Clin Endocrinol (Oxf) (2011) 0.81
In silico optimization of basal insulin infusion rate during exercise: implication for artificial pancreas. J Diabetes Sci Technol (2013) 0.81
Effect of bilateral carotid body resection on the counterregulatory response to hypoglycaemia in humans. Exp Physiol (2015) 0.81
Bariatric surgery and diabetes: Implications of type 1 versus insulin-requiring type 2. Obesity (Silver Spring) (2015) 0.81
Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans. Int Immunol (2003) 0.81
Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes. Diabetes Care (2005) 0.81
Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study. Diabetes Technol Ther (2012) 0.81
Do the carotid bodies modulate hypoglycemic counterregulation and baroreflex control of blood pressure in humans? Adv Exp Med Biol (2012) 0.81
Fat-induced liver insulin resistance. Curr Diab Rep (2003) 0.81
Autonomic control during acute hypoglycemia in type 1 diabetes mellitus. Clin Auton Res (2014) 0.80
Using implantation biopsies as a surrogate to evaluate selection criteria for living kidney donors. Transplantation (2013) 0.80
Detection of myocardial microvascular disease using contrast echocardiography during adenosine stress in type 2 diabetes mellitus: prospective comparison with single-photon emission computed tomography. Diab Vasc Dis Res (2011) 0.80
Role of the carotid body chemoreceptors in baroreflex control of blood pressure during hypoglycaemia in humans. Exp Physiol (2014) 0.80
Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-kidney transplantation. Transplantation (2004) 0.80
Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans. Am J Physiol Endocrinol Metab (2002) 0.80
Diabetes mellitus and the Moyamoya syndrome. Ann Intern Med (2012) 0.79